New Delhi : In view of the rising COVID cases in the country and the emergence of highly transmissible Omicron, The Health Ministry in the revised guidelines informed that the beneficiaries between the ages of 15-18 years now have the option of getting vaccinated with Covaxin only. The vaccination would …
Read More »covaxin: Bharat Biotech ramps up Covaxin production capacity to 700 mn doses per annum
To support vaccination campaigns in India and across the globe, Bharat Biotech has ramped up the manufacturing capacity of its COVID-19 vaccine, Covaxin, to 700 million doses per annum, the vaccine maker said on Tuesday. Manufacturing scale up has been carried out in a stepwise manner across multiple facilities at …
Read More »Brazilian regulator says Bharat Biotech’s Covaxin manufacturing facility fails to meet CGMP standards, Health News, ET HealthWorld
The Brazilian health regulator Anvisa has denied permission to import Bharat Biotech’s Covid-19 vaccine Covaxin into the country after its authorities found that the plant in which the vaccine is being made did not meet the Current Good Manufacturing Practice (CGMP) requirements. Reacting to it, the city-based vaccine maker said …
Read More »